Term ends Mar 20, 2037 · High confidence
20-year base term ends Nov 23, 2036
Held by Immunocore Limited
Filed May 17, 2018 as application 15/777,153 · Granted Nov 17, 2020
Base term plus 117 days of patent term adjustment (USPTO delay)
Today
2016
2037
Clock starts
Nov 23, 2016
Nov 23, 2016
Term ends
Mar 20, 2037
Mar 20, 2037
Granted
Nov 17, 2020
Nov 17, 2020
base term
patent term adjustment
fee events
Updated Nov 14, 2026 · includes USPTO assignment & status data published Nov 14, 2026 and grant & fee data published Nov 10, 2026 (weekly) · how we know
117
Days of term adjustment
Read from the USPTO patent term adjustment record, not recalculated here.
None
Terminal disclaimer
No disclaimer on this record.
1 of 3
Maintenance fees paid
Three maintenance fees fall due, at 3.5, 7.5 and 11.5 years from grant. This counts the ones the record shows paid.
5
Family applications on record here
Applications sharing this one's continuity chain whose file history this site holds. The family may have others.
This patent's term runs 117 days past its 20-year base term on prosecution delay. 1 of 3 maintenance fees is paid so far. Confidence: High. from the record
How we calculated this date
One row per rule, each showing its own input and what it did to the date. A step we could not verify says so instead of resolving itself.
| Step | Input | Date after this step | Confidence |
|---|---|---|---|
| Base term, 20 years from filing | Clock starts Nov 23, 2016, when application PCT/GB2016/053637, the earliest non-provisional in its chain, was filed (this one was filed May 17, 2018) | Nov 23, 2036 | High confidence |
| Continuity chain | Every parent in the chain resolved | no change | High confidence |
| Patent term adjustment | +117 days, USPTO patent term adjustment record | Mar 20, 2037 | High confidence |
| Terminal disclaimer cap | None on record | no cap applied | High confidence |
| Patent term extension | None on file | no change | High confidence |
| Fee events | 1 of 3 maintenance fees paid | In force | High confidence |
| Computed term end | The steps above, in order | Mar 20, 2037 | High confidence |
This family
| US 10,835,577 | this patent Mar 2037 | Mar 2037 |
| Application 17/065,509 | Abandoned not computed | not computed |
| Application 18/149,664 | Abandoned not computed | not computed |
| Application 18/908,671 | Pending not computed | not computed |
4 of 5 applications in this family shown, earliest filings first. The applications whose file history this site holds. The family may have others.
Assignments
Assignment documents as recorded at the USPTO, oldest first, with the reel and frame each was recorded at. A recorded assignment is a filed document, not a statement of current ownership, and the absence of a later one is not evidence that the last one still stands.
| Recorded | Assignor | Assignee | Conveyance |
|---|---|---|---|
| Sep 6, 2019 Reel 50299, frame 107 | Powlesland, Alex; Chillakuri, Chandramouli; Sangani, Dhaval; Popa, Alina | Immunocore Limited | Assignment of Assignor's Interest |
| Feb 27, 2020 Reel 51954, frame 414 | Hood, Graham | Immunocore Limited | Assignment of Assignor's Interest |
| Nov 6, 2020 Reel 54344, frame 218 | Immunocore Limited; Immunocore LLC; Immunocore Commercial LLC | Oxford Finance Luxembourg S.À R.L., Registered with the Luxembourg Commercial Register Under Number B243395, Acting in Respect of Its Compartment 1 | Security Interest |
| Nov 30, 2020 Reel 54496, frame 211 | Immunocore Ltd. | Immunocore Ltd.; Adaptimmune Therapeutics PLC | Assignment of Assignor's Interest |
| Nov 30, 2020 reel/frame not recorded | Immunocore Ltd. | Immunocore Ltd. | Assignment of Assignor's Interest |
| Nov 30, 2020 reel/frame not recorded | Immunocore Ltd. | Adaptimmune Therapeutics PLC | Assignment of Assignor's Interest |
| Feb 4, 2021 Reel 55153, frame 407 | Adaptimmune Therapeutics PLC | Adaptimmune Limited | Assignment of Assignor's Interest |
| Nov 10, 2022 Reel 61916, frame 493 | Oxford Finance Luxembourg S.À R.L | Immunocore Limited; Immunocore LLC; Immunocore Commercial LLC | Release of Security Interest |
| Nov 10, 2022 reel/frame not recorded | Oxford Finance Luxembourg S.À R.L | Immunocore Limited | Release of Security Interest |
| Nov 10, 2022 reel/frame not recorded | Oxford Finance Luxembourg S.À R.L | Immunocore LLC | Release of Security Interest |
| Nov 10, 2022 reel/frame not recorded | Oxford Finance Luxembourg S.À R.L | Immunocore Commercial LLC | Release of Security Interest |
| Jun 24, 2026 Reel 75813, frame 266 | Adaptimmune Limited | Immunocore Limited | Assignment of Assignor's Interest |
Sources
Google Patents · The patent document at USPTO · Assignment records at USPTO
USPTO account required: This application in Patent Center · USPTO's maintenance fee lookup
Maintenance fee events come from USPTO's own fee records. Its fee lookup asks for the patent number and the application number.
Free plan: 3 watched companies. Pro: unlimited.
Alerts on its grants, lapses and transfers.
What's changing
Mar 2037
Term ends Mar 20, 2037. Maintenance fees still fall due before then
Note
The 117 days of patent term adjustment (USPTO delay) are read from the USPTO record, not recalculated by us
Citations
10
later US patents cite this one
That is top 25% of utility patents granted in 2020 in our data, the only group it is compared against.
How we rank
Every date shows its work: the base term, any term adjustment or extension, any disclaimer cap, and the maintenance fee record, each with a confidence tier. How this record was built
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.
In force means the term is running and no lapse is on record. It is not a finding that the patent is valid.